Does carvedilol added to standard therapy reduce clinical progression in patients with mildly symptomatic, well-compensated heart failure?
Carvedilol added to standard therapy including an ACE inhibitor is effective at reducing clinical progression in patients with mildly symptomatic heart failure.
Carvedilol, when added to standard therapy, including an ACE inhibitor, reduces clinical progression in patients who are only mildly symptomatic with well-compensated heart failure.
Colucci et al. (Sun,) studied this question.